ERG and prostate neoplasm: The technological advances in next-generation sequencing have empowered the deep genomic and epigenomic characterization of localized and castration-resistant prostate tumor samples, revealing patterns of mutual exclusivity between ERG rearrangements and other key alterations (Figure 2 and [12,13]).